REFERENCES
1. Bukavina L, Bensalah K, Bray F, et al. Epidemiology of renal cell carcinoma: 2022 update. Eur Urol. 2022;82:529-42.
2. Lim A, O’Neil B, Heilbrun ME, Dechet C, Lowrance WT. The contemporary role of renal mass biopsy in the management of small renal tumors. Front Oncol. 2012;2:106.
3. Lane BR, Babineau D, Kattan MW, et al. A preoperative prognostic nomogram for solid enhancing renal tumors 7 cm or less amenable to partial nephrectomy. J Urol. 2007;178:429-34.
4. Campbell SC, Clark PE, Chang SS, Karam JA, Souter L, Uzzo RG. Renal mass and localized renal cancer: evaluation, management, and follow-up: AUA Guideline: part I. J Urol. 2021;206:199-208.
5. Ljungberg B, Albiges L, Abu-Ghanem Y, et al. European Association of Urology Guidelines on renal cell carcinoma: the 2022 update. Eur Urol. 2022;82:399-410.
6. Motzer RJ, Jonasch E, Agarwal N, et al. NCCN Guidelines® Insights: kidney cancer, Version 2.2024. J Natl Compr Canc Netw. 2024;22:4-16.
7. Frank I, Blute ML, Cheville JC, Lohse CM, Weaver AL, Zincke H. Solid renal tumors: an analysis of pathological features related to tumor size. J Urol. 2003;170:2217-20.
8. Thompson RH, Kurta JM, Kaag M, et al. Tumor size is associated with malignant potential in renal cell carcinoma cases. J Urol. 2009;181:2033-6.
9. Lane BR, Golan S, Eggener S, et al. Differential use of partial nephrectomy for intermediate and high complexity tumors may explain variability in reported utilization rates. J Urol. 2013;189:2047-53.
10. Lebentrau S, Rauter S, Baumunk D, et al. Nephron sparing surgery for renal cell carcinoma up to 7 cm in the context of guideline development: a contribution of healthcare research. World J Urol. 2017;35:753-9.
11. Thompson RH, Kaag M, Vickers A, et al. Contemporary use of partial nephrectomy at a tertiary care center in the United States. J Urol. 2009;181:993-7.
12. Campbell SC, Uzzo RG, Karam JA, Chang SS, Clark PE, Souter L. Renal mass and localized renal cancer: evaluation, management, and follow-up: AUA Guideline: part II. J Urol. 2021;206:209-18.
13. Salka BR, Boynton D, Nwachukwu C, et al. Concordance of surgical treatment selection with the AUA guidelines for localized renal masses. Urol Oncol. 2025;43:394.e23-9.
14. Moch H, Cubilla AL, Humphrey PA, Reuter VE, Ulbright TM. The 2016 WHO Classification of Tumours of the Urinary System and Male Genital Organs-Part A: renal, penile, and testicular tumours. Eur Urol. 2016;70:93-105.
15. Diaz de Leon A, Davenport MS, Silverman SG, Schieda N, Cadeddu JA, Pedrosa I. Role of virtual biopsy in the management of renal masses. AJR Am J Roentgenol. 2019;212:1234-43.
16. Moch H, Amin MB, Berney DM, et al. The 2022 World Health Organization Classification of Tumours of the Urinary System and Male Genital Organs-Part A: renal, penile, and testicular tumours. Eur Urol. 2022;82:458-68.
17. Finelli A, Ismaila N, Bro B, et al. Management of small renal masses: American Society of Clinical Oncology Clinical Practice Guideline. J Clin Oncol. 2017;35:668-80.
18. Wang Y, Butaney M, Wilder S, Ghani K, Rogers CG, Lane BR. The evolving management of small renal masses. Nat Rev Urol. 2024;21:406-21.
19. Hussain S, Mubeen I, Ullah N, et al. Modern diagnostic imaging technique applications and risk factors in the medical field: a review. Biomed Res Int. 2022;2022:5164970.
20. Pedrosa I, Cadeddu JA. How we do it: managing the indeterminate renal mass with the MRI clear cell likelihood score. Radiology. 2022;302:256-69.
21. Salles-Silva E, Lima EM, Amorim VB, Milito M, Parente DB. Clear cell likelihood score may improve diagnosis and management of renal masses. Abdom Radiol. 2024;49:4494-506.
22. Wolf JS. Evolving role of renal mass biopsy: myths, facts, and misconceptions. In: Leveillee RJ, Jorda M, editors. Renal mass biopsy. Cham: Springer International Publishing; 2020. pp. 1-12.
23. Ali SN, Tano Z, Landman J. The changing role of renal mass biopsy. Urol Clin North Am. 2023;50:217-25.
24. Lane BR, Samplaski MK, Herts BR, Zhou M, Novick AC, Campbell SC. Renal mass biopsy - a renaissance? J Urol. 2008;179:20-7.
25. Marconi L, Dabestani S, Lam TB, et al. Systematic review and meta-analysis of diagnostic accuracy of percutaneous renal tumour biopsy. Eur Urol. 2016;69:660-73.
26. Patel HD, Johnson MH, Pierorazio PM, et al. Diagnostic accuracy and risks of biopsy in the diagnosis of a renal mass suspicious for localized renal cell carcinoma: systematic review of the literature. J Urol. 2016;195:1340-7.
28. Leveillee RJ, Peairs S, Nields MW. Renal mass biopsy: simple techniques and optimizing navigational/targeting tools. In: Leveillee RJ, Jorda M, editors. Renal mass biopsy. Cham: Springer International Publishing; 2020. pp. 71-102.
29. Richard PO, Violette PD, Bhindi B, et al. Canadian Urological Association guideline: management of small renal masses - full-text. Can Urol Assoc J. 2022;16:E61-75.
30. Andersen MF, Norus TP. Tumor seeding with renal cell carcinoma after renal biopsy. Urol Case Rep. 2016;9:43-4.
31. Volpe A, Kachura JR, Geddie WR, et al. Techniques, safety and accuracy of sampling of renal tumors by fine needle aspiration and core biopsy. J Urol. 2007;178:379-86.
33. Mullins JK, Rodriguez R. Renal cell carcinoma seeding of a percutaneous biopsy tract. Can Urol Assoc J. 2013;7:E176-9.
34. Smith EH. Complications of percutaneous abdominal fine-needle biopsy. Review. Radiology. 1991;178:253-8.
35. Menhadji AD, Nguyen V, Okhunov Z, et al. Technique for office-based, ultrasonography-guided percutaneous biopsy of renal cortical neoplasms using a novel transducer for facilitated ultrasound targeting. BJU Int. 2016;117:948-53.
36. Dave CN, Seifman B, Chennamsetty A, et al. Office-based ultrasound-guided renal core biopsy is safe and efficacious in the management of small renal masses. Urology. 2017;102:26-30.
37. Rasmussen LR, Loft M, Nielsen TK, et al. Short-term complications for percutaneous ultrasound-guided biopsy of renal masses in adult outpatients. Acta Radiol. 2018;59:491-6.
38. Jiang P, Arada RB, Okhunov Z, et al. Multidisciplinary approach and outcomes of pretreatment small (cT1a) renal mass biopsy: single-center experience. J Endourol. 2022;36:703-11.
39. Patel RM, Okhunov Z, Jiang P, Tapiero S, Landman J. Office-based renal tumor biopsy: a paradigm change in the management of a small renal mass? Curr Urol Rep. 2021;22:43.
40. Faraj K, Dave CN, Patel K, et al. A retrospective comparative outcomes and cost analysis of office based, ultrasound guided renal mass biopsy performed by urologists and standard hospital biopsies for small renal masses. Urol Pract. 2018;5:260-5.
41. Patel RM, Safiullah S, Okhunov Z, et al. Pretreatment diagnosis of the small renal mass: status of renal biopsy in the United States of America. J Endourol. 2018;32:884-90.
42. Khan AA, Shergill IS, Quereshi S, Arya M, Vandal MT, Gujral SS. Percutaneous needle biopsy for indeterminate renal masses: a national survey of UK consultant urologists. BMC Urol. 2007;7:10.
43. Jiang P, Ali SN, Peta A, et al. A review of the recommendations and strength of evidence for clinical practice guidelines on the management of small renal masses. J Endourol. 2023;37:903-13.
44. Patel HD, Druskin SC, Rowe SP, Pierorazio PM, Gorin MA, Allaf ME. Surgical histopathology for suspected oncocytoma on renal mass biopsy: a systematic review and meta-analysis. BJU Int. 2017;119:661-6.
45. Abel EJ, Culp SH, Matin SF, et al. Percutaneous biopsy of primary tumor in metastatic renal cell carcinoma to predict high risk pathological features: comparison with nephrectomy assessment. J Urol. 2010;184:1877-81.
46. Al Nazer M, Mourad WA. Successful grading of renal-cell carcinoma in fine-needle aspirates. Diagn Cytopathol. 2000;22:223-6. Available from: https://doi.org/10.1002/(SICI)1097-0339(200004)22:4%3C223::AID-DC4%3E3.0.CO;2-B. [Last accessed on 17 Sep 2025].
47. Ball MW, Bezerra SM, Gorin MA, et al. Grade heterogeneity in small renal masses: potential implications for renal mass biopsy. J Urol. 2015;193:36-40.
48. Nahouraii LM, Allen JL, Merrill SB, Lehman E, Kaag MG, Raman JD. Histologic heterogeneity of extirpated renal cell carcinoma specimens: implications for renal mass biopsy. J Kidney Cancer VHL. 2020;7:20-5.
49. Millet I, Curros F, Serre I, Taourel P, Thuret R. Can renal biopsy accurately predict histological subtype and Fuhrman grade of renal cell carcinoma? J Urol. 2012;188:1690-4.
50. Blumenfeld AJ, Guru K, Fuchs GJ, Kim HL. Percutaneous biopsy of renal cell carcinoma underestimates nuclear grade. Urology. 2010;76:610-3.
51. Johnson DC, Vukina J, Smith AB, et al. Preoperatively misclassified, surgically removed benign renal masses: a systematic review of surgical series and United States population level burden estimate. J Urol. 2015;193:30-5.
52. Kim JH, Li S, Khandwala Y, Chung KJ, Park HK, Chung BI. Association of prevalence of benign pathologic findings after partial nephrectomy with preoperative imaging patterns in the United States from 2007 to 2014. JAMA Surg. 2019;154:225-31.
53. Gao H, Nowroozizadeh B, Zepeda JP, et al. The success rate of small renal mass core needle biopsy and its impact on lowering benign resection rate. BMC Urol. 2023;23:189.
54. Patel HD, Nichols PE, Su ZT, et al. Renal mass biopsy is associated with reduction in surgery for early-stage kidney cancer. Urology. 2020;135:76-81.
55. Patel DN, Ghali F, Meagher MF, et al. Utilization of renal mass biopsy in patients with localized renal cell carcinoma: a population-based study utilizing the National Cancer Database. Urol Oncol. 2021;39:79.e1-8.
56. Boynton DN, Mirza M, Van Til M, et al. Renal mass biopsy is associated with fewer radical nephrectomies for benign or indolent disease, particularly for T1b renal masses. Urol Pract. 2025;12:148-56.
57. Volpe A, Finelli A, Gill IS, et al. Rationale for percutaneous biopsy and histologic characterisation of renal tumours. Eur Urol. 2012;62:491-504.
58. Tong W, Lin X, Xu Y, Yan Y. The role of percutaneous fine needle aspiration biopsy in the management of small renal masses without chance of nephron-sparing surgery. Int Urol Nephrol. 2020;52:2223-8.
59. Sinks A, Miller C, Holck H, et al. Renal mass biopsy mandate is associated with change in treatment decisions. J Urol. 2023;210:72-8.
60. Srivastava A, Uzzo RN, Lee J, et al. Renal mass biopsy: a strategy to reduce associated costs and morbidity when managing localized renal masses. Urol Oncol. 2021;39:790.e9-15.
61. Chung R, Kurtzman JT, Gillespie A, et al. The utility of renal mass biopsy in shared decision-making for renal mass treatment. Urology. 2023;178:98-104.
62. Branger N, Bigot P, Pignot G, et al. Oncocytoma on renal mass biopsy: is it still the same histology when surgery is performed? Results from UroCCR-104 study. World J Urol. 2023;41:483-9.
63. Couture F, Finelli T, Breau RH, et al. The increasing use of renal tumor biopsy amongst Canadian urologists: when is biopsy most utilized? Urol Oncol. 2021;39:499.e15-22.
64. Richard PO, Jewett MA, Bhatt JR, et al. Renal tumor biopsy for small renal masses: a single-center 13-year experience. Eur Urol. 2015;68:1007-13.
65. Wang X, Lv Y, Xu Z, et al. Accuracy and safety of ultrasound-guided percutaneous needle core biopsy of renal masses: a single center experience in China. Medicine. 2018;97:e0178.
66. Ma LX, Craig KM, Mosquera JM, et al. Contemporary results and clinical utility of renal mass biopsies in the setting of ablative therapy: a single center experience. Cancer Treat Res Commun. 2020;25:100209.
67. Chen S, Chen Y, Li J, et al. Accuracy, safety, and diagnostic prediction of percutaneous renal mass biopsy and subsequent changes in treatment. Wideochir Inne Tech Maloinwazyjne. 2024;19:113-21.
68. Tolouee SA, Madsen M, Berg KD, Dahl C, Fode M, Azawi NH. Renal tumor biopsies are associated with a low complication rate. Scand J Urol. 2018;52:407-10.
69. Lobo JM, Clements MB, Bitner DP, et al. Does renal mass biopsy influence multidisciplinary treatment recommendations? Scand J Urol. 2020;54:27-32.
70. Kutikov A, Smaldone MC, Uzzo RG, Haifler M, Bratslavsky G, Leibovich BC. Renal mass biopsy: always, sometimes, or never? Eur Urol. 2016;70:403-6.
71. Menon AR, Hussein AA, Attwood KM, et al. Active surveillance for risk stratification of all small renal masses lacking predefined clinical criteria for intervention. J Urol. 2021;206:229-39.
72. Gao B, Gorgen ARH, Bhatt R, et al. Avoiding “Needless” nephrectomy: what is the role of small renal mass biopsy in 2024? Urol Oncol. 2024;42:236-44.
73. Ambani SN, Morgan TM, Montgomery JS, et al. Predictors of delayed intervention for patients on active surveillance for small renal masses: does renal mass biopsy influence our decision? Urology. 2016;98:88-96.
74. Jorgenson LC, Navin PJ, Adamo D, et al. Imaging and nonsurgical management of renal masses. Radiographics. 2025;45:e240093.
75. Wells SA, Wong VK, Wittmann TA, et al. Renal mass biopsy and thermal ablation: should biopsy be performed before or during the ablation procedure? Abdom Radiol. 2017;42:1773-80.
76. Takafuji M, Fujimori M, Nakatsuka A, et al. Computed tomography-guided biopsy for small renal masses before or immediately after tumor ablation: factors affecting diagnostic yield. Jpn J Radiol. 2021;39:283-92.
77. Uhlig A, Lenis A, Wang X, Shuch B. Sequencing of renal mass biopsy and ablation: results from the National Cancer Database. Urol Pract. 2021;8:555-64.
78. Doganca T, Obek C. Evaluation of diagnostic accuracy of percutaneous biopsy for small renal masses and first report of post-biopsy adhesions: a prospective study. Urol J. 2019;16:357-60.
79. Pasquier D, Rozet F, Fregeville A, et al. Renal tumor biopsy does not increase the risk of surgical complications of minimally invasive partial nephrectomy. Prog Urol. 2022;32:843-8.
80. Kumar S, Virarkar M, Vulasala SSR, et al. Magnetic resonance imaging virtual biopsy of common solid renal masses - a pictorial review. J Comput Assist Tomogr. 2023;47:186-98.
81. Johnson BA, Kim S, Steinberg RL, de Leon AD, Pedrosa I, Cadeddu JA. Diagnostic performance of prospectively assigned clear cell Likelihood scores (ccLS) in small renal masses at multiparametric magnetic resonance imaging. Urol Oncol. 2019;37:941-6.
82. Steinberg RL, Rasmussen RG, Johnson BA, et al. Prospective performance of clear cell likelihood scores (ccLS) in renal masses evaluated with multiparametric magnetic resonance imaging. Eur Radiol. 2021;31:314-24.
83. Chen KY, Lange MJ, Qiu JX, et al. Cost-effectiveness analysis of the clear cell likelihood score against renal mass biopsy for evaluating small renal masses. Urology. 2024;188:111-7.
84. Shuch B, Pantuck AJ, Bernhard JC, et al. [89Zr]Zr-girentuximab for PET-CT imaging of clear-cell renal cell carcinoma: a prospective, open-label, multicentre, phase 3 trial. Lancet Oncol. 2024;25:1277-87.
85. Barwari K, de la Rosette JJ, Laguna MP. The penetration of renal mass biopsy in daily practice: a survey among urologists. J Endourol. 2012;26:737-47.
86. Curci N, Caoili EM. The current role of biopsy in the diagnosis of renal tumors. Semin Ultrasound CT MR. 2017;38:72-7.
87. Londoño DC, Wuerstle MC, Thomas AA, et al. Accuracy and implications of percutaneous renal biopsy in the management of renal masses. Perm J. 2013;17:4-7.
88. Bernhard JC, Bigot P, Pignot G, et al; NEPHRON Study Group. The accuracy of renal tumor biopsy: analysis from a national prospective study. World J Urol. 2015;33:1205-11.
89. Garnon J, Schlier A, Buy X, et al. Evaluation of percutaneous biopsies of renal masses under MRI-guidance: a retrospective study about 26 cases. Eur Radiol. 2015;25:617-23.
90. Prince J, Bultman E, Hinshaw L, et al. Patient and tumor characteristics can predict nondiagnostic renal mass biopsy findings. J Urol. 2015;193:1899-904.
91. Jeon HG, Seo SI, Jeong BC, et al. Percutaneous kidney biopsy for a small renal mass: a critical appraisal of results. J Urol. 2016;195:568-73.
92. Alle N, Tan N, Huss J, Huang J, Pantuck A, Raman SS. Percutaneous image-guided core biopsy of solid renal masses: analysis of safety, efficacy, pathologic interpretation, and clinical significance. Abdom Radiol. 2018;43:1813-9.
93. Tsang Mui Chung MS, Maxwell AW, Wang LJ, Mayo-Smith WW, Dupuy DE. Should renal mass biopsy be performed prior to or concomitantly with thermal ablation? J Vasc Interv Radiol. 2018;29:1240-4.
94. Posielski NM, Bui A, Wells SA, et al. Risk factors for complications and nondiagnostic results following 1,155 consecutive percutaneous core renal mass biopsies. J Urol. 2019;201:1080-7.
95. Gillis CJ, Rendon R, MacDonald LP, et al. Identification of tumor size as the only factor associated with nondiagnostic biopsies in patients with small renal masses. Can Urol Assoc J. 2020;14:E220-3.
96. Santy A, Basset V, Colleter L, et al. Operative and oncological results and impact on treatment strategy of systematic renal tumor biopsy: comparison between patients < and >75 years old. Urol Oncol. 2020;38:74.e21-7.
97. Shahait M, Jackman S, Landman J, et al. Utilization and operative influence of renal mass biopsy in the small renal mass: analysis from the Clinical Research Office of the Endourological Society Small Renal Mass Registry. J Endourol. 2020;34:99-106.
98. Bada M, Rapisarda S, Cicero C, et al. The role of renal biopsy to improve small renal mass diagnosis and management: are there predictive factors for a higher detection rate?. The first Italian study of 100 cases. Minerva Urol Nephrol. 2021;73:78-83.
99. Ferrari M, Cartolari R, Barizzi J, Pereira Mestre R, D’Antonio E, Renard J. Percutaneous biopsy of small renal mass: can diagnostic accuracy be affected by hospital volume? Cent European J Urol. 2021;74:334-40.
100. Masic S, Strother M, Kidd LC, et al. Feasibility and outcomes of renal mass biopsy for anatomically complex renal tumors. Urology. 2021;158:125-30.
101. Jasinski M, Siekiera J, Tworkiewicz M. Ultrasound-guided renal mass biopsy and its clinical utility: a single-centre experience. Urol Int. 2022;106:560-6.
102. Kapur P, Setoodeh S, Araj E, et al. Improving renal tumor biopsy prognostication with BAP1 analyses. Arch Pathol Lab Med. 2022;146:154-65.
103. Nazzani S, Zaborra C, Biasoni D, et al. Renal tumor biopsy in patients with cT1b-T4-M0 disease susceptible to radical nephrectomy: analysis of safety, accuracy and clinical impact on definitive management. Scand J Urol. 2022;56:367-72.
104. Valtersson J, Rasmussen BS, Elgborn A, Lund L, Graumann O. One hour observation of patients after image-guided percutaneous renal mass biopsy. Acta Radiol Open. 2022;11:20584601221138555.
105. Serhal M, Rangwani S, Seedial SM, et al. Safety and diagnostic efficacy of image-guided biopsy of small renal masses. Cancers. 2024;16:835.
106. Garbens A, Wallis CJD, Klaassen Z, et al. Comprehensive assessment of the morbidity of renal mass biopsy: a population-based assessment of biopsy-related complications. Can Urol Assoc J. 2021;15:42-7.
107. Ozambela M Jr. , Wang Y, Leow JJ, Silverman SG, Chung BI, Chang SL. Contemporary trends in percutaneous renal mass biopsy utilization in the United States. Urol Oncol. 2020;38:835-43.
108. Patel AK, Lane BR, Chintalapati P, et al. Utilization of renal mass biopsy for T1 renal lesions across michigan: results from MUSIC-KIDNEY, a statewide quality improvement collaborative. Eur Urol Open Sci. 2021;30:37-43.
109. Staehler M, Rodler S, Brinkmann I, et al. Long-term follow-up in patients undergoing renal mass biopsy: seeding is not anecdotal. Clin Genitourin Cancer. 2024;22:189-92.
110. Robert SC, Cossetto T, Miao TL, et al. Complications after renal mass biopsy: frequency, nature, timing, and associated characteristics. AJR Am J Roentgenol. 2023;221:344-53.
111. Beisland C, Johannesen TB, Reisæter LAR, Hjelle KM. Real-life use of diagnostic biopsies before treatment of kidney cancer: results from a Norwegian population-based study. Scand J Urol. 2018;52:38-44.
112. Michel J, Lenis AT, Lec PM, et al. Analysis of guideline recommended use of renal mass biopsy and association with treatment. Can J Urol. 2020;27:10285-93.
113. Okhunov Z, Gorin MA, Jefferson FA, et al. Can preoperative renal mass biopsy change clinical practice and reduce surgical intervention for small renal masses? Urol Oncol. 2021;39:735.e17-23.
114. Neuzillet Y, Lechevallier E, Andre M, Daniel L, Coulange C. Accuracy and clinical role of fine needle percutaneous biopsy with computerized tomography guidance of small (less than 4.0 cm) renal masses. J Urol. 2004;171:1802-5.
115. Buijs M, Wagstaff PGK, de Bruin DM, et al. An in-vivo prospective study of the diagnostic yield and accuracy of optical biopsy compared with conventional renal mass biopsy for the diagnosis of renal cell carcinoma: the interim analysis. Eur Urol Focus. 2018;4:978-85.
116. Amaral BS, Macek P, Arora A, et al. Renal tumor biopsy: rationale to avoid surgery in small renal masses. Curr Urol Rep. 2021;22:46.
